The Longitude Prize is a £10 million ($12.5 million) project designed to incentivise the development of a rapid diagnostic test to improve the use of antibiotics. Daniel represents Nesta in international One Health forums designed to address the challenge of antimicrobial resistance. This includes championing new strategies to address the market failure that has led to a lack of diagnostic products to address AMR.
Prior to Nesta, Daniel worked for the World Health Organization in Ethiopia on a local pharmaceutical production project. Previous to that he was at Médecins Sans Frontières (MSF) for more than 16 years. At MSF he had multiple assignments in the Access to Medicines Campaign which focuses on stimulating and steering innovation and access to medicines, diagnostics and vaccines. From 2012-2015 Daniel was General Director of MSF Southern Africa, based in Johannesburg, South Africa. Daniel is currently a Trustee for QUAMED, a French NGO that supports humanitarian organisations and national procurement institutions to improving the quality of medicines.